PMHNP Practice Test PDF (Free Printable 2026 October)
🎯 Boost your PMHNP exam score with practice questions and detailed answer explanations. Track progress with instant feedback.
PMHNP Practice Test PDF – Free Printable Psychiatric Mental Health Nurse Practitioner Exam Prep
Preparing for the PMHNP-BC (Psychiatric Mental Health Nurse Practitioner-Board Certified) certification exam? A printable PMHNP practice test PDF gives you an offline format to review psychopathology, psychopharmacology, psychotherapy, advanced psychiatric assessment, and ethical-legal practice that the ANCC PMHNP-BC exam assesses. Working through psychiatric NP exam questions on paper reinforces the clinical reasoning and diagnostic knowledge that psychiatric mental health NPs apply across the lifespan. This page provides a free PDF download and a comprehensive PMHNP exam preparation guide.
The PMHNP-BC credential is issued by the American Nurses Credentialing Center (ANCC) and is the primary certification for advanced practice registered nurses (APRNs) specializing in psychiatric mental health care. PMHNPs provide independent assessment, diagnosis, and treatment of mental health and substance use disorders, including prescriptive authority for psychotropic medications in most states.
Key Takeaway: Psychiatric-Mental Health Nurse Practitioner Exam certification demonstrates expertise in this field. Most candidates spend 4-8 weeks preparing with practice tests before taking the exam.
What the PMHNP-BC Exam Covers
The PMHNP-BC exam tests advanced practice knowledge across psychiatric assessment, diagnosis, and treatment. Your PMHNP practice test PDF covers all major content domains.
Psychiatric Assessment and Diagnosis
Assessment questions cover the comprehensive psychiatric evaluation: mental status examination (MSE) components — appearance, behavior, speech, mood vs. affect distinction, thought process vs. content, perceptual disturbances, cognitive status, insight, and judgment. DSM-5-TR diagnostic criteria for major psychiatric disorders are heavily tested: major depressive disorder (MDD — 5 of 9 criteria for 2+ weeks, including depressed mood or anhedonia), bipolar I vs. II distinctions (manic episode criteria — 7 days, full criteria; hypomanic — 4 days, no hospitalization), schizophrenia spectrum disorders (positive symptoms: hallucinations, delusions, disorganized speech; negative symptoms: alogia, avolition, anhedonia), anxiety disorders (GAD — 6+ months worry; panic disorder — discrete episodes with somatic symptoms), PTSD (trauma exposure + intrusion + avoidance + cognition/mood + arousal changes), and personality disorders (Cluster A/B/C characteristics).
Psychopharmacology
Psychopharmacology is the most heavily tested PMHNP content area. Antidepressants: SSRIs (mechanism: serotonin reuptake inhibition; side effects: sexual dysfunction, GI, discontinuation syndrome; serotonin syndrome risk with MAOIs), SNRIs (venlafaxine, duloxetine — additional norepinephrine; BP monitoring), bupropion (NDRI — no sexual side effects; seizure risk, contraindicated in eating disorders/seizure history), TCAs (amitriptyline, nortriptyline — anticholinergic effects; lethal in overdose), MAOIs (tyramine dietary restrictions — hypertensive crisis risk). Mood stabilizers: lithium (narrow therapeutic index 0.6–1.2 mEq/L; renal monitoring; toxicity signs: tremor, ataxia, confusion), valproate (teratogenic — neural tube defects; liver function monitoring), lamotrigine (titrate slowly — Stevens-Johnson syndrome risk). Antipsychotics: first-generation (haloperidol — EPS risk: pseudoparkinsonism, akathisia, dystonia, TD), second-generation (clozapine — agranulocytosis requires ANC monitoring; olanzapine — metabolic syndrome; quetiapine; risperidone — hyperprolactinemia). Benzodiazepines: mechanism (GABA-A potentiation), dependence risk, withdrawal dangers (seizures — distinguish from opioid withdrawal).
Psychotherapy Modalities
Evidence-based psychotherapy knowledge includes: CBT (cognitive behavioral therapy — thought records, behavioral activation, exposure therapy for anxiety/OCD/PTSD), DBT (dialectical behavior therapy — developed by Linehan for BPD; four skill modules: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness), motivational interviewing (MI — stages of change; OARS technique: Open questions, Affirmations, Reflective listening, Summarizing), and psychodynamic therapy (transference, countertransference, resistance). Know the first-line therapy modality for each major disorder: CBT for MDD/anxiety/OCD; CPT or prolonged exposure for PTSD; DBT for BPD; family therapy for eating disorders in adolescents.
Lifespan Considerations and Special Populations
PMHNP exam tests psychiatric care across age groups: pediatric psychopharmacology (FDA black-box warning: SSRIs increase suicidal ideation in children/adolescents — require informed consent and monitoring), ADHD management (stimulants first-line — monitor cardiovascular; non-stimulants: atomoxetine, guanfacine), geriatric considerations (Beers Criteria — avoid benzodiazepines, anticholinergics; late-onset psychosis differential: dementia with Lewy bodies vs. delirium vs. late-onset schizophrenia), and perinatal mental health (postpartum depression — bruxanolone/brexanolone; SSRIs considered relatively safe in pregnancy; lithium risk: Ebstein's anomaly).
How to Use This PDF
Prioritize psychopharmacology — it's the highest-yield PMHNP content area. After this PDF, take online PMHNP practice tests at psychiatric mental health nurse practitioner for instant scored feedback by domain.
- ✓Memorize DSM-5 criteria: MDD (5/9 for 2+ wks), bipolar I manic episode (7 days), schizophrenia (6+ months)
- ✓Study lithium: therapeutic range 0.6–1.2 mEq/L, toxicity signs, renal/thyroid monitoring requirements
- ✓Know antipsychotic side effects: EPS (haloperidol), metabolic syndrome (olanzapine), agranulocytosis (clozapine)
- ✓Review SSRI serotonin syndrome: hyperthermia + clonus + agitation — especially with MAOIs or tramadol
- ✓Study MSE components: appearance, behavior, speech rate/volume/tone, mood vs. affect, thought process vs. content
- ✓Know DBT skills: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness — for BPD
- ✓Review FDA black-box warning: SSRIs + suicidal ideation in < 25 years old — monitor first 4 weeks
- ✓Study benzodiazepine withdrawal: seizures possible — unlike opioid withdrawal, benzo withdrawal is life-threatening
- ✓Know first-line treatments: CBT for anxiety/depression, CPT/PE for PTSD, DBT for BPD, lithium for bipolar
- ✓Review ANCC exam format: 175 total (150 scored), 3.5 hours — time per question ~72 seconds
Free PMHNP Practice Tests Online
After completing this PDF, take full online PMHNP practice tests at psychiatric mental health nurse practitioner — instant scoring across psychiatric assessment, psychopharmacology, psychotherapy, and professional practice with explanations for every answer. Use both: PDF for offline pharmacology and DSM review, online for timed exam simulation and tracking your performance toward PMHNP-BC certification.
Sample Psychiatric-Mental Health Nurse Practitioner Exam Practice Questions
Try these questions from our free Psychiatric-Mental Health Nurse Practitioner Exam practice tests. The correct answer and an explanation follow each question.
A PMHNP is initiating lithium therapy. Which baseline laboratory test is MOST critical before starting treatment?
- A. Hemoglobin A1c
- B. Serum creatinine and thyroid-stimulating hormone (TSH)
- C. Lipid panel and fasting glucose
- D. Liver function tests and CBC
Answer: B. Serum creatinine and thyroid-stimulating hormone (TSH)
Renal function (creatinine/GFR) and thyroid function (TSH) must be assessed before lithium initiation because lithium is renally cleared and causes hypothyroidism with long-term use.
A PMHNP learns during therapy that a patient is being physically abused by a caregiver. What is the PMHNP's legal obligation?
- A. Maintain confidentiality because the patient is an adult
- B. Report the suspected abuse to appropriate authorities as a mandatory reporter
- C. Consult with the patient about whether they want the abuse reported
- D. Refer the patient to a social worker to handle the report
Answer: B. Report the suspected abuse to appropriate authorities as a mandatory reporter
PMHNPs are mandatory reporters in all U.S. states and are legally required to report suspected abuse of vulnerable individuals, including adults who may be incapacitated, to protective services.
A PMHNP discovers that a colleague is prescribing controlled substances to patients without appropriate clinical indications. The PMHNP's ethical obligation is to:
- A. Ignore the situation as it involves a colleague
- B. Report the behavior through appropriate institutional or regulatory channels
- C. Confront the colleague publicly at a staff meeting
- D. Only act if a patient files a formal complaint
Answer: B. Report the behavior through appropriate institutional or regulatory channels
Ethical and legal obligations require PMHNPs to report unsafe or illegal prescribing practices through appropriate channels such as hospital administration, the state board of nursing, or the DEA.
A PMHNP is treating an adolescent with depression and learns the patient disclosed abuse by a family member. The PMHNP's FIRST legal and ethical obligation is to:
- A. Discuss the disclosure with the patient's parents before acting
- B. Maintain confidentiality to preserve the therapeutic alliance
- C. Report the suspected abuse to the appropriate child protective services
- D. Consult a colleague before making any report
Answer: C. Report the suspected abuse to the appropriate child protective services
As a mandated reporter, the PMHNP must immediately report suspected child abuse to child protective services regardless of the therapeutic relationship or parental consent.
Take the full Psychiatric-Mental Health Nurse Practitioner Exam practice test